Effector Therapeutics Completes Enrollment In Second Of Three Cohorts Of Phase 1B Clinical Trial Of Zotatifin For The Treatment Of COVID-19

  • Nevan Krogan

Press/Media

Period26 Oct 2022

Media coverage

1

Media coverage

  • TitleEffector Therapeutics Completes Enrollment In Second Of Three Cohorts Of Phase 1B Clinical Trial Of Zotatifin For The Treatment Of COVID-19
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date26/10/22
    PersonsNevan Krogan